packageAlglucerase

alglucerase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Alglucerase is an enzyme replacement therapy that was used to treat Gaucher disease, a condition involving liver and spleen enlargement. It has been withdrawn from the market, having been superseded by a newer version of the enzyme produced by recombinant DNA technology.

Summary written by glm-5.3-flash from Wikidata Q4724257 and the WHO ATC classification; not checked by a person.

name:alglucerase
ATC codes:A16AB01
DrugBank:DB00088
Wikidata:Q4724257
molar mass:55597.4 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown